main-logo

ICD-10 Code C81.4A | Lymphocyte-rich Hodgkin lymphoma, in remission Symptoms, Diagnosis, Billing

Lymphocyte-rich Hodgkin lymphoma is a subtype of Hodgkin lymphoma characterized by a predominance of lymphocytes. It is associated with a favorable prognosis and can be effectively treated. The ICD-10 Code C81.4A is crucial for accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission?

ICD-10 Code C81.4A represents Lymphocyte-rich Hodgkin lymphoma, in remission, indicating that the disease is currently not active. This code is used when documenting patients who have undergone treatment and are showing no signs of disease progression. Accurate coding is essential for proper billing and to reflect the patient's clinical status.

ICD-10 Code C81.4A – Clinical Definition and Explanation of Lymphocyte-rich Hodgkin lymphoma, in remission

Lymphocyte-rich Hodgkin lymphoma is a rare form of Hodgkin lymphoma that features a high number of lymphocytes and is typically associated with a better prognosis. The condition requires medical attention due to its potential to progress if left untreated. Regular monitoring and appropriate treatment are essential for maintaining remission.

Key Clinical Features:

  • Presence of abundant lymphocytes in histological examination.
  • Commonly presents with lymphadenopathy, fever, and night sweats.
  • Typically affects younger adults, with a slight male predominance.
  • Responds well to chemotherapy and radiation therapy.

ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C81.4A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status.

What Does ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.4A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Lymphocyte-rich Hodgkin lymphoma, in remission. This ensures continuity of care and supports accurate billing and compliance with EHR documentation standards.

Treatment Options for ICD-10 Code C81.4A – Lymphocyte-rich Hodgkin lymphoma, in remission

Management of Lymphocyte-rich Hodgkin lymphoma, in remission, focuses on monitoring and supportive care to maintain the patient's health status.

Antibiotic Therapy:

  • Not typically indicated unless there is an infection; consider prophylactic antibiotics in immunocompromised patients.
  • First-line: Amoxicillin 500 mg TID for 7-10 days if infection is suspected.
  • Alternative: Cephalexin 500 mg QID for 7-10 days.

Supportive Care:

  • Regular follow-up appointments for monitoring.
  • Symptom management including pain control and nutritional support.
  • Psychosocial support and counseling services.

Infection Control:

  • Encourage good hygiene practices.
  • Monitor for signs of infection, especially in immunocompromised patients.
  • Educate patients on avoiding exposure to infectious agents.

How to Document Symptoms of Lymphocyte-rich Hodgkin lymphoma, in remission (ICD-10 C81.4A) in SOAP Notes

Subjective:

  • Patient reports feeling well with no new symptoms.
  • Denies fever, night sweats, or weight loss.
  • History of previous lymphadenopathy, now resolved.

Objective:

  • Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
  • Physical examination shows no palpable lymphadenopathy.
  • Laboratory results within normal limits.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Lymphocyte-rich Hodgkin lymphoma, in remission (ICD-10 Code C81.4A)

Assessment:

  • Diagnosis: Lymphocyte-rich Hodgkin lymphoma, in remission.
  • ICD-10 Code: C81.4A.
  • No current symptoms or signs of disease activity.

Plan:

  • Continue regular follow-up every 3-6 months.
  • Monitor for any recurrence of symptoms.
  • Educate patient on signs of potential relapse.

Treatment & Plan Section for ICD-10 Code C81.4A – Lymphocyte-rich Hodgkin lymphoma, in remission

  • Regular follow-up appointments to monitor remission status.
  • Patient education on lifestyle modifications and symptom awareness.
  • Consider routine imaging if clinically indicated.
  • Psychosocial support services to assist with emotional well-being.

Using ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of patient history and clinical findings.
  • Use C81.4A in settings where remission status is confirmed.
  • Align treatment plans with clinical guidelines to support billing.
  • Include relevant CPT codes that correspond to services provided.

    ICD-10 Code C81.4A in Medical Billing and Insurance for Lymphocyte-rich Hodgkin lymphoma, in remission

    ICD-10 Code C81.4A is essential for accurate billing in hospital, ER, or infectious disease care settings.

    Billing Notes:

    • Document all relevant clinical findings and treatment plans.
    • Use C81.4A when the patient is confirmed to be in remission.
    • Ensure that documentation supports the medical necessity of services provided.

    Common CPT Pairings:

    CPT CodeDescription
    99213Established patient office visit, low complexity.
    36415Collection of venous blood by venipuncture.
    85025Complete blood count with automated differential.

    Frequently Asked Questions

    Common Questions About Using ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission

    What does it mean to be in remission from Lymphocyte-rich Hodgkin lymphoma?

    Being in remission means that the signs and symptoms of Lymphocyte-rich Hodgkin lymphoma have decreased or disappeared following treatment. Regular monitoring is essential to ensure that the disease does not return.

    How is Lymphocyte-rich Hodgkin lymphoma treated?

    Treatment typically involves chemotherapy and may include radiation therapy. The specific regimen depends on the stage of the disease and the patient's overall health.

    Is Lymphocyte-rich Hodgkin lymphoma contagious?

    No, Lymphocyte-rich Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and cannot be transmitted from person to person.

    What follow-up care is needed after remission?

    Patients in remission should have regular follow-up appointments to monitor for any signs of recurrence. This may include physical exams, imaging studies, and blood tests.

    diamond-bg
    diamond-bg

    Get started with your 20 free notes

    Sign up for free
    main-logo

    AI-aided Sudsy Shorthand for ink-free practices

    support@soapsuds.io
    hipaa-logo

    Clinical Notes

    SOAP notes

    DAP notes

    AI medical notes

    © Copyright SOAPsuds 2025. All rights reserved